Maricann Group Inc. Announces 2017 AGM Results
TORONTO, ONTARIO–(Marketwired – Dec. 18, 2017) -
NOT FOR DISSEMINATION IN THE U.S. OR THROUGH U.S. NEWSWIRE SERVICES
Maricann Group Inc. (CSE:MARI)(CSE:MARI.CN)(CNSX:MARI)(OTCQB:MRRCF)(FRANKFURT:75M) (“Maricann” or the “Company”) is pleased to announce that the nominees listed in the management information circular dated November 10, 2017 (the “Circular“), Ben Ward, Neil Tabatznik, Raymond Stone, Eric Silver, Gerhard Muller, Paul Pathak and Michael Stein, were elected as directors of the Company at the annual and special meeting of shareholders of the Company (the “Meeting“) held on December 15, 2017. At the Meeting, shareholders also approved all of the other resolutions put before them as set out in the Circular, including approving the Company’s 2017 rolling stock option plan.
About Maricann Group Inc.
Maricann, which has federal licenses in Canada to cultivate, extract, formulate and distribute cannabis, is rapidly expanding its Canadian production, based in Norfolk County, Ontario, targeting to add 22,245 kg of annual production of dry flower to come online in Q2 2018, with additional production planned. The company announced on November 8, 2017 that Health Canada had granted Maricann Inc. a new licence that removes annual production limits on approved medical cannabis products in its Canadian growing facility.
For more information about Maricann, please visit our website at www.maricann.ca
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
Not for dissemination or distribution in the United States or through U.S. newswire services.
Corporate Headquarters (Canada)
Maricann Group Inc. (Toronto)
845 Harrington Court, Unit 3
Burlington Ontario L7N 3P3
European Headquarters (Germany)
Thierschstrasse 3, 80538 Munchen, Deutschland